Peptide Drug Discovery Market

Peptide Drug Discovery Market by Type of Product, Type of Drug Discovery Steps, Type of Therapeutic Area, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2020-2030

  • Lowest Price Guaranteed From USD 4,899

  • Companies Covered
    115

  • Pages
    240

  • View Count
    24629

Peptide Drug Discovery Market Overview

The peptide drug discovery market is estimated to be worth $560 million in 2020 and is expected to grow at compounded annual growth rate (CAGR) of 10.5% during the forecast period.Over the past few years, peptides (including oligopeptides, polypeptides and synthetic peptides) and macrocycle-based pharmacological interventions have gained a lot of attention from clinical researchers; drug development efforts focused on such molecules have significantly increased. This can be attributed to the benefits offered by the aforementioned drug classes, which include high target specificity, low toxicity and favorable safety profiles. In fact, more than 60 peptide-based therapies and macrocycle drug molecules have been approved till date, across the globe. In addition, more than 400 peptide based drugs are currently being evaluated in clinical trials, while over 500 molecules are still in the early stages of development.  

It has been reported that the overall process of drug development, from peptide discovery of a molecule to its commercial launch, takes around 10-15 years and involves capital investments worth USD 4-10 billion. However, only a small proportion of the molecules, which are selected for further investigation during the initial stages of research, actually enter the market. Given the complexities associated with the peptide drug discovery process, the overall research and development (R&D) expenditure in the pharmaceutical / biotechnology sector has steadily increased over time. Specifically, the discovery of peptides and macrocycles for therapeutic use is a long, arduous and cost intensive process. As a result, many developers are opting to outsource such operations to contract research organizations (CROs) that claim to specialize in this regard. In addition, there are multiple technology platform providers, which offer licenses to proprietary peptide discovery platforms that can be used by interested drug developers / manufacturers. We believe that, as the demand for peptide-based therapeutics increases, the opportunity for contract service provides and technology developers engaged in peptide drug discovery market is also likely to witness a substantial market growth during the forecast period.

This image highlights the context of Peptides Drug Discovery Services Market report. Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities This image provides list of Peptides and Macrocycles Discovery: Service Providers. More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates This image provides list of Peptides and Macrocycles Discovery Platform Providers. Several technology developers have made significant contributions in terms of developing novel platforms, based on a variety of innovative approaches, for the discovery of peptide-based drugs and macrocyclic molecules

Key Companies in Peptide Drug Discovery Market

Examples of key companies engaged in peptide drug discovery market (which have also been profiled in this market report; the complete list of companies is available in the full report) include GenScript, JPT Peptide Technologies, CPC Scientific, IRBM, Creative Peptides, Pepscan, Interprotein, RA Pharmaceuticals, Pepticom, PeptiDream, Creative Biolabs and MeSCue-Janusys. This market report includes an easily searchable excel database of all the companies providing peptide drug discovery platforms and services, worldwide.

Recent Developments in Peptide Drug Discovery Market:

Several recent developments have taken place in the field of peptide drug discovery market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In June 2023, IRBM announced the extension of its peptide therapeutics focused collaboration with Merck. 
  • In May 2023, Fujitsu launched Biodrug Design Accelerator platform with an aim to accelerate peptide drug discovery research. 
  • In March 2023, Arch Biopartners raised USD 4,000,000 funds from the National Research Council of Canada Industrial Research Assistance Program in order to support the research and development of the LSALT peptide (Metablok) program.

Scope of the Report

The “Peptide Drug Discovery Market, 2020-2030” market report features an extensive study on the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the peptide drug discovery market. The market research report includes in-depth analyses, highlighting the capabilities of various service / technology providers engaged in this market. Amongst other elements, the market research report includes:

  • A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services, including developer information (year of establishment, company size and location of headquarters), type of peptide manufactured (linear, cyclic, helical and others), drug discovery steps covered in service portfolio (target validation, hit identification, lead generation and lead optimization), peptide generation methods used (liquid phase synthesis, solid phase synthesis, microwave-assisted synthesis, recombinant methods and others), peptide modification services (C-terminal, N-terminal, fret / quenching tags, immunogenic conjugates, linkers / spacers, unnatural AAS, cyclization, stable isotope labels and post-translational modification services) and other services offered (peptide isolation / purification service, peptide detection / identification service and peptide quantification service).
  • An insightful geographical benchmarking of the capabilities of companies of various sizes, highlighting the key focus areas, comparing their existing strengths both within and beyond their respective peer groups (based on geography and company size). 
  • An in-depth analysis of peptide platform and library service providers, featuring information on their company details (year of establishment, company size and location of headquarters), purpose of the platform, type of peptide manufactured (linear, cyclic, helical and others) and platform access model (pipeline licensing, technology licensing, strategic alliance and library provider).
  • Profiles of peptides and macrocycle drug discovery service providers, featuring information on the year of establishment, location of headquarters, peptide discovery service / platform portfolio, recent developments and an informed future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering R&D agreements, licensing agreements, acquisitions and other form of collaborations.

The key objective of peptide drug discovery market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity for peptide drug discovery market during the forecast period. Based on multiple parameters, such as R&D spend, we have developed an informed estimate on the financial evolution of the market over the forecast period, 2020-2030. The market report also provides details on the likely distribution of the current and forecasted opportunity across [A] different type of product (synthetic peptides, biological and recombinant peptides and macrocycles), [B]  drug discovery steps (target identification and validation, hit identification, lead generation and lead optimization), [C] therapeutic area (oncological disorders, metabolic disorders, cardiovascular disorders, infectious disorders, urological disorders, endocrine disorders, CNS disorders, and other diseases), [D] company size (small, mid-sized and large and very large companies) and [E] geography (North America, Europe, Asia Pacific). To account for the uncertainties associated with the drug discovery services and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution. 

This image highlights competitive analysis of players engaged in the domain of Peptides Drug Discovery Services Market. Service providers are expanding their capabilities in order to enhance their respective portfolios; display libraries have emerged amongst the most popular platforms This image highlights the partnership activity undertaken by players engaged in Peptides Drug Discovery Services Market. In recent years, a steady increase in partnership activity has been observed, resulting in the establishment of a variety of deals related to different types of peptides and macrocycles This image highlights the market segments of Peptides and Macrocycle Service Providers. Drug developers are likely to continue to outsource discovery stage operations for therapeutic peptides and macrocyclic drugs in mid to long term, resulting in multi-billion growth for contract service providers

The opinions and insights presented in the market report were influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interview(s) held with the following industry stakeholders:

  • Mark L Peterson (Chief Operating Officer, Cyclenium Pharma)
  • Anonymous

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What is peptide drug discovery?

Answer: Peptide drug discovery refers to the process of identifying potential therapeutic peptides followed by biological or synthetic modifications to enhance its pharmacological effectiveness.

Question 2: How big is the peptide drug discovery market?

Answer: The peptide drug discovery market size is estimated to be worth $560 million in 2020.

Question 3: What is the projected market growth of the peptide drug discovery market?

Answer: The peptide drug discovery market is expected to grow at compounded annual growth rate (CAGR) of 10.5% during the forecast period 2020 – 2030.

Question 4: Who are the leading players in the peptide drug discovery market?

Answer: Examples of key companies engaged in peptide drug discovery market (which have also been profiled in this market report; the complete list of companies is available in the full report) include GenScript, JPT Peptide Technologies, CPC Scientific, IRBM, Creative Peptides, Pepscan, Interprotein, RA Pharmaceuticals, Pepticom, PeptiDream, Creative Biolabs and MeSCue-Janusys.

Question 5: How many companies are currently offering peptide drug discovery services?

Answer: Over 35 companies are currently offering peptide drug discovery services.

Question 6: How many companies are currently offering peptide drug discovery platforms?

Answer: Over 20 companies are currently offering peptide drug discovery platforms.

Question 7: How many partnership deals have been inked between the companies engaged in peptide drug discovery market?

Answer: More than 55 partnership deals have been inked between the players engaged in peptide drug discovery market, highlighting the consolidation efforts of stakeholders in the industry.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com